Table 5.
Group | M | P | C | I | Con | Isc | Id | H | A | T | W |
---|---|---|---|---|---|---|---|---|---|---|---|
A (n : 38) | 3 (7%) | 0 | 0 | 0 | 0 | 0 | 17 (44%) | 6 (15%) | 2 (7%) | 6 (15%) | 3 (7%) |
B (n : 36) | 15 (41%) | 1 (2%) | 6 (16%) | 4 (11%) | 2 (5%) | 2 (5%) | 3 (8%) | 0 | 1 (2%) | 1 (2%) | 1 (2%) |
C (n : 26) | 10 (38%) | 1 (3%) | 0 | 0 | 0 | 0 | 8 (30%) | 0 | 1 (3%) | 6 (23%) | 0 |
P | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 | ≤0.01 |
(M: malignancy, P: postoperative, C: cardiac perforation from invasive procedure, I: infection, Con: connectice tissue diseas, Isc: ischemic heart disease related, Id: idiopathic, H: hypotroidiea, A: acute rheomatismal fewer, T: tuberculosis, W: warfarin overdose).